Vanguard Group’s Ambit Biosciences Corp AMBI Stock Holding History

Vanguard Group’s Portfolio AMBI Stock Details AMBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-282,451	Closed	-$4.35M	–	4076
2014 Q3	$4.35M	Buy	282,451 +27,098	+11%	+$186K	﹤0.01%	2912
2014 Q2	$1.76M	Buy	255,353 +42,655	+20%	+$299K	﹤0.01%	3313
2014 Q1	$1.94M	Buy	212,698 +138,744	+188%	+$1.47M	﹤0.01%	3237
2013 Q4	$713K	Buy	73,954 +34,973	+90%	+$467K	﹤0.01%	3504
2013 Q3	$604K	Buy	+38,981	New	+$517K	﹤0.01%	3504

Vanguard Group's AMBI Position: Q4 2014 in Review

Vanguard Group sold out of Ambit Biosciences Corp (AMBI) in Q4 2014, closing a stake of 282,451 shares — an estimated $4.35M sold.

Vanguard Group first reported a position in AMBI in Q3 2013 and held it in 5 quarters. The position peaked at $4.35M in Q3 2014. 0 funds tracked by Wall St. Rank hold AMBI as of Q4 2014.

Vanguard Group reported no remaining Ambit Biosciences Corp position as of Q4 2014 after selling out during the quarter.
Vanguard Group sold 282,451 Ambit Biosciences Corp shares in Q4 2014, an estimated $4.35M.
Vanguard Group first reported a position in Ambit Biosciences Corp in Q3 2013 and held it in 5 quarters.
Vanguard Group's Ambit Biosciences Corp position peaked at $4.35M in Q3 2014.
0 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2014.

Based on Vanguard Group's 13F filing for Q4 2014, filed 12 Feb 2015.